Acrivon Therapeutics Inc [ACRV] stock prices are up 1.84% to $1.66 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ACRV shares have gain 9.93% over the last week, with a monthly amount glided 25.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On September 16, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $16 on the stock. Ladenburg Thalmann downgraded its rating to a Neutral. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $14 as its price target on March 01, 2024. In a note dated October 05, 2023, Maxim Group initiated a Buy rating.
The stock price of Acrivon Therapeutics Inc [ACRV] has been fluctuating between $1.05 and $8.74 over the past year. Currently, Wall Street analysts expect the stock to reach $21.83 within the next 12 months. Acrivon Therapeutics Inc [NASDAQ: ACRV] shares were valued at $1.66 at the most recent close of the market. An investor can expect a potential return of 1215.06% based on the average ACRV price forecast.
Analyzing the ACRV fundamentals
Gross Profit Margin for this corporation currently stands at -1.43% with Operating Profit Margin at -111.33%, Pretax Profit Margin comes in at -101.37%, and Net Profit Margin reading is -101.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.54, Equity is -0.51 and Total Capital is -0.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5933 points at the first support level, and at 1.5267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7133, and for the 2nd resistance point, it is at 1.7667.
Ratios To Look Out For
It’s worth pointing out that Acrivon Therapeutics Inc [NASDAQ:ACRV]’s Current Ratio is 10.31. Further, the Quick Ratio stands at 10.31, while the Cash Ratio is 3.12.
Transactions by insiders
Recent insider trading involved PERCEPTIVE ADVISORS LLC, 10% Owner, that happened on Apr 30 ’25 when 0.44 million shares were sold. 10% Owner, PERCEPTIVE ADVISORS LLC completed a deal on May 01 ’25 to sell 0.3 million shares. Meanwhile, 10% Owner PERCEPTIVE ADVISORS LLC sold 1.05 million shares on Apr 25 ’25.
